News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Research Published In Journal Of Biotechnology Highlights Utility Of InVitria’s Recombinant Human Leukemia Inhibitory Factor In Stem Cell Culture


1/6/2014 9:29:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FORT COLLINS, Colo.--(BUSINESS WIRE)--InVitria, a division of Ventria Bioscience, today announced publication of new research demonstrating that InVitria’s animal-component–free recombinant human leukemia inhibitory factor (rhLIF) is comparable to traditional sources of recombinant LIF for the maintenance of pluripotent mouse embryonic stem cells (ESC) in culture.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
InVitria
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES